𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma

✍ Scribed by Qing-Yu He; Rui Zhu; Ting Lei; Mandy Y.M. Ng; John M. Luk; Pak Sham; George K.K. Lau; Jen-Fu Chiu

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
348 KB
Volume
103
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Early detection is a key step for effective intervention of hepatocellular carcinoma (HCC), the lack of sensitive and specific biomarkers is a major reason for the high rate of HCC‐related mortality. This report described an integrated strategy by combining SELDI‐ProteinChip, sophisticated algorithm analysis, acetonitrile (ACN) pre‐treatment and two‐dimensional electrophoresis (2DE)–peptide mass fingerprinting (PMF) techniques to identify serological markers for the prediction of HBV‐related HCC. Proteomic profiling of three groups of serum specimens from HBV‐related HCC (50 cases), HBV infection (45 cases), and normal subjects (30 cases) was conducted by using SELDI‐ProteinChip system and the resulting different protein peaks were subjected to stepwise statistical analyses. Three most discriminatory peaks at 5890, 11615, and 11724 Da, respectively, were screened out from the statistical algorithm and a predictive model based on the three peaks was constructed and tested using the newly enrolled serum samples. 2DE was applied to separate and compare the serum samples that were pre‐treated by ACN precipitation. The protein spots obviously intensified in HCC sera in the 2DE region of 12 kDa were identified by PMF to be serum SAA, which was validated by SELDI‐TOF spectra of HCC sera after immunoprecipitation using anti‐SAA antibody and by Western blot experiments. Given the fact that SAA is not a specific biomarker, further attempt is being made to identify the other two most discriminatory peaks to realize the possibility of using the predictive model for HCC surveillance and prediction. J. Cell. Biochem. 103: 740–752, 2008. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Predicting the risk of tumor recurrence
Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma
✍ J W Marsh; A Casavilla; S Iwatsuki; I Dvorchik; M Subotin; V Balan; J Rakela; V 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

be either higher or lower than 1, i.e., having serological mark-to the exposure of interest, constitute a valid and well-accepted comparison group, which has been used in countless ers of infection by hepatitis B and C viruses could be either ''protective'' or ''predisposing'' factors for aplastic a

Can the prognosis of liver transplantati
Can the prognosis of liver transplantation for hepatocellular carcinoma be predicted?
✍ B Ringe 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

Slow-growing tumors have the best prognosis. It is increasingly clear that hepatitis B and C play a role in the develop-Hepatocellular carcinoma (HCC), one of the most frequent ment and progression of HCC both before and after liver malignant tumors in the world, can be fatal if untreated. transplan

Design of proteome-based studies in comb
Design of proteome-based studies in combination with serology for the identification of biomarkers and novel targets
✍ Barbara Seliger; Roland Kellner 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 2 views

Recently proteome analysis has rapidly developed in the post-genome era and is now widely accepted as a complementary technology to genetic profiling. The improvement in the technology of both two-dimensional electrophoresis (2-DE) analysis as well as protein identification has made proteomics a val